Ubs Group Ag Vertex Pharmaceuticals Inc Call Options Transaction History

Ubs Group Ag

$400 Billion
Q2 2024

Call Options

14 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 13, 2024	BUY	$392.81 - $485.53 $628,496 - $776,848	1,600 Added 2.55%	64,300 $30.1 Million
Q1 2024 May 13, 2024	SELL	$407.69 - $446.08 $1.43 Million - $1.56 Million	-3,500 Reduced 5.29%	62,700 $26.2 Million
Q4 2023 Feb 09, 2024	SELL	$343.0 - $410.68 $89,180 - $106,776	-260 Reduced 0.39%	66,200 $26.9 Million
Q3 2023 Nov 09, 2023	BUY	$338.18 - $362.46 $8.61 Million - $9.23 Million	25,460 Added 62.1%	66,460 $23.1 Million
Q2 2023 Aug 11, 2023	BUY	$314.42 - $351.91 $4.24 Million - $4.75 Million	13,500 Added 49.09%	41,000 $14.4 Million
Q1 2023 May 12, 2023	BUY	$283.23 - $323.1 $7.02 Million - $8.01 Million	24,800 Added 918.52%	27,500 $8.66 Million
Q4 2022 Feb 08, 2023	BUY	$285.76 - $321.48 $771,552 - $867,996	2,700 New	2,700 $779,000
Q1 2022 May 16, 2022	BUY	$221.42 - $260.97 $497,752 - $586,660	2,248 Added 7.54%	32,048 $8.36 Million
Q4 2021 Feb 14, 2022	SELL	$177.01 - $223.45 $485,184 - $612,476	-2,741 Reduced 8.42%	29,800 $6.54 Million
Q2 2021 Aug 13, 2021	BUY	$187.49 - $221.1 $2.79 Million - $3.29 Million	14,900 Added 84.46%	32,541 $6.56 Million
Q1 2021 May 12, 2021	SELL	$207.02 - $241.31 $6.4 Million - $7.46 Million	-30,924 Reduced 63.68%	17,641 $3.79 Million
Q3 2018 Nov 14, 2018	BUY	$167.73 - $192.74 $7.73 Million - $8.88 Million	46,065 Added 1842.6%	48,565 $9.36 Million
Q2 2018 Aug 14, 2018	SELL	$145.72 - $169.96 $1.49 Million - $1.73 Million	-10,200 Reduced 80.31%	2,500 $425,000
Q4 2017 Feb 14, 2018	BUY	$137.28 - $155.55 $1.74 Million - $1.98 Million	12,700	12,700 $1.9 Million

Others Institutions Holding VRTX

# of Institutions

1,716

Shares Held

225M

Call Options Held

1.19M

Put Options Held

1.56M

Capital World Investors Los Angeles, CA

26.7M
Shares

$13.4 Billion
2.1% of portfolio
Vanguard Group Inc Valley Forge, PA

23M
Shares

$11.5 Billion
0.21% of portfolio
Black Rock Inc. New York, NY

21.3M
Shares

$10.7 Billion
0.23% of portfolio
State Street Corp Boston, MA

11.7M
Shares

$5.89 Billion
0.24% of portfolio
Capital Research Global Investors Los Angeles, CA

8.54M
Shares

$4.29 Billion
0.9% of portfolio

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $129B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account